Concerns with the new biological research criteria for synucleinopathy.

Boeve, Bradley F; Davis, Albert A; Ju, Yo-El; Kantarci, Kejal; Singer, Wolfgang; Videnovic, Aleks

Boeve, Bradley F; Davis, Albert A; Ju, Yo-El; Kantarci, Kejal; Singer, Wolfgang; Videnovic, Aleks.

Affiliation

Boeve BF; Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: bboeve@mayo.edu.
Davis AA; Department of Neurology, Washington University, St. Louis, MO, USA.
Ju YE; Department of Neurology, Washington University, St. Louis, MO, USA.
Kantarci K; Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Singer W; Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
Videnovic A; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Lancet Neurol ; 23(7): 659-660, 2024 Jul.

Article in En | MEDLINE | ID: mdl-38876735

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Synucleinopathies Limits: Humans Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2024 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google